Sonographic measurement of endometrial thickness as a predictor of vaginal bleeding in women using continuous combined hormone replacement therapy

Gynecologic and Obstetric Investigation

Volumn 44, Issue 3, 1997, Pages 187-190

  Haines, C J ^a   Chung, T K H ^a   Lau, T K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Endometrium; Hormone replacement therapy; Menopause; Ultrasound

Indexed keywords

ESTROGEN; GESTAGEN; HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ECHOGRAPHY; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; PREDICTION; PRIORITY JOURNAL; THICKNESS; TIME; VAGINA BLEEDING;

EID: 0030657411     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291516     Document Type: Article

References (9)

1. Woodruff JD, Picker JH, for the Menopause Study Group: Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. Am J Obstet Gynecol 1994:170:1212-1223.
2. Casper RF, Chapdelaine A: Estrogen and interrupted progestin: A new concept for hormone replacement therapy. Am J Obstet Gynecol 1993;168:1188-1196.
3. MacLennan AH, MacLennan A, Wenzel S, Chambers HM, Eckert K: Continuous low-dose estrogen and progestogen hormone replacement therapy: A randomized trial. Med J Aust 1993;159:102-106.
4. Mattsson L, Cullbcrg G, Samsoie G: Evaluation of a continuous combined estrogen/pro-gestogen regimen for climacteric complaints. Maturitas 1982;4:95-102.
5. Staland B: Continuous treatment with a combination of estrogen and gestagen: A way of avoiding endometrial stimulation. Acta Obstet Gynecol Scand 1982; 130 (suppl):29-35.
6. Magos A, Brincat M, Studd JW, Wardle P, Schlesingcr P, O'Dowd T: Amenorrhoea and endometrial atrophy with continuous oral estrogens and progestogen therapy in post-meno-pausal women. Obstet Gynecol 1985;65:469-499.
7. Dorcn M, Rcuther G, Minne HW, Schneider HPG: Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol 1995; 173:1446-1451.
8. Coope J, Marsh J: Can we improve compliance with long-term HRT? Maturitas 1992; 15:151-158.
9. Christiansen C, Riis BJ: Five years with continuous combined estrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins and bleeding pattern. Br J Obstet Gynaecol 1990;97:1087-1092.